Blood Pressure Outcomes With Liraglutide Therapy

NCT01755572 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Systolic Hypertension

Interventions

DRUG: Liraglutide
DRUG: Placebo

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]